ETH Zürich (Switzerland) and the United States National Cancer Institute (NCI) have just signed an extension of their MOU for Proteogenomics Cancer Research

Exciting news! ETH Zürich (Switzerland) and the United States National Cancer Institute (NCI) have just signed an extension of their MOU for Proteogenomics Cancer Research. Proud to have the Switzerland International Cancer Proteogenome Consortium (ICPC) team at ETH Zürich, contributing to our cancer moonshot global fight against cancer. Together, we’re pushing the boundaries of science to fight against this relentless disease. https://lnkd.in/ex4vhTFP

Source: Henry Rodriguez / LinkedIn